Concepedia

Gianpaolo Bravi

GB

22

Publications

1.5K

Citations

18

H-Index

1994

Active since

Affiliations

Eli Lilly (United States)(Current)

GlaxoSmithKline (United Kingdom)

Italfarmaco (Italy)

Lusofarmaco (Italy)

University of Sheffield

Gianpaolo Bravi is an author at Eli Lilly (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1994–2019

22

Publications

22

A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP

Yogendra Patel, Valerie J. Gillet, Gianpaolo Bravi et al. · Journal of Computer-Aided Molecular Design · 2002 · 131 citations

Lead Optimization Using Matched Molecular Pairs: Inclusion of Contextual Information for Enhanced Prediction of hERG Inhibition, Solubility, and Lipophilicity

George Papadatos, M. Alkarouri, Valerie J. Gillet et al. · Journal of Chemical Information and Modeling · 2010 · 130 citations

, , +23

Three- and Four-Dimensional Quantitative Structure Activity Relationship Analyses of Cytochrome P-450 3A4 Inhibitors

Sean Ekins, Gianpaolo Bravi, Shelly Binkley et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 127 citations

Three-Dimensional-Quantitative Structure Activity Relationship Analysis of Cytochrome P-450 3A4 Substrates

Sean Ekins, Gianpaolo Bravi, James H. Wikel et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 125 citations

MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids

Gianpaolo Bravi, Emanuela Gancia, Paolo Mascagni et al. · Journal of Computer-Aided Molecular Design · 1997 · 113 citations

Rows per page

1–5 of 22